Cigdem Aydogmus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cigdem Aydogmus has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Işılay Turan
Department of Pediatric Allergy and Immunology Basaksehir Cam and Sakura City Hospital Istanbul Turkiye
8 shared publications - Selami Ulaş
Department of Pediatric Allergy and Immunology Basaksehir Cam and Sakura City Hospital Istanbul Turkiye
7 shared publications - Sezin Naiboğlu
Department of Pediatric Allergy and Clinical Immunology Başakşehir Çam and Sakura City Hospital İstanbul Türkiye
6 shared publications - Ayca Kiykim
Department of Pediatric Allergy and Immunology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
5 shared publications - Esra Yucel
Cerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology Istanbul University‐Cerrahpasa Istanbul Turkiye
5 shared publications - Haluk Cokugras
Department of Pediatric Allergy and Immunology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
5 shared publications
Latest Publications
- 2 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity
Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image
- 2 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity
Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image
- 19 October 2026
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 69 (1) , 86
Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency
- 19 October 2026
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 69 (1) , 86
Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency
- 1 July 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 104 (1) , e70133
Recent Thymic Emigrant Levels in Inborn Errors of Immunity: Is Their Diagnostic Value Greater Than We Think?
We aimed to evaluate the sensitivity and specificity of Recent Thymic Emigrant (RTE) levels for diagnostic discrimination among various Inborn Errors of Immunity (IEI) subgroups. We analysed 205 paediatric patients diagnosed with IEI at the Paediatric Immunology and Allergy Department of Başakşehir Çam and Sakura City Hospital in Istanbul between January 2021 and January 2024. An age‐ and sex‐matched control group consisting of 31 healthy children was also included for comparison. Demographic, clinical and laboratory data were evaluated. Reduced RTE levels were identified in 39% of all patients. Low RTE levels were most pronounced in patients with syndromic combined immunodeficiency (77%) and immune dysregulation (100%), and were also observed at high frequencies in combined immunodeficiency (CID) (60%) and autoinflammatory disorders (57.1%). For the syndromic CID group, the diagnostic performance of RTE yielded an area under the curve (AUC) of 0.80, with a sensitivity of 92% and a specificity of 52%. In the immune dysregulation group, the AUC was 0.79, with a sensitivity of 83.5% and a specificity of 57.1%. Assessment of RTE levels represents a valuable diagnostic biomarker, particularly for patients within the syndromic CID and immune dysregulation categories. This parameter may contribute meaningfully to clinical practice by facilitating early diagnosis, guiding genetic testing and enabling assessment of thymic function. Incorporating thymic output assessment into routine immunophenotyping panels may shorten the diagnostic timeline for IEI and allow earlier initiation of appropriate therapies.
- 1 July 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 104 (1) , e70133
Recent Thymic Emigrant Levels in Inborn Errors of Immunity: Is Their Diagnostic Value Greater Than We Think?
We aimed to evaluate the sensitivity and specificity of Recent Thymic Emigrant (RTE) levels for diagnostic discrimination among various Inborn Errors of Immunity (IEI) subgroups. We analysed 205 paediatric patients diagnosed with IEI at the Paediatric Immunology and Allergy Department of Başakşehir Çam and Sakura City Hospital in Istanbul between January 2021 and January 2024. An age‐ and sex‐matched control group consisting of 31 healthy children was also included for comparison. Demographic, clinical and laboratory data were evaluated. Reduced RTE levels were identified in 39% of all patients. Low RTE levels were most pronounced in patients with syndromic combined immunodeficiency (77%) and immune dysregulation (100%), and were also observed at high frequencies in combined immunodeficiency (CID) (60%) and autoinflammatory disorders (57.1%). For the syndromic CID group, the diagnostic performance of RTE yielded an area under the curve (AUC) of 0.80, with a sensitivity of 92% and a specificity of 52%. In the immune dysregulation group, the AUC was 0.79, with a sensitivity of 83.5% and a specificity of 57.1%. Assessment of RTE levels represents a valuable diagnostic biomarker, particularly for patients within the syndromic CID and immune dysregulation categories. This parameter may contribute meaningfully to clinical practice by facilitating early diagnosis, guiding genetic testing and enabling assessment of thymic function. Incorporating thymic output assessment into routine immunophenotyping panels may shorten the diagnostic timeline for IEI and allow earlier initiation of appropriate therapies.
- Open Access
- 19 June 2026
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 46 (1)
Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report
Gain-of-function (GOF) mutations in the STAT1 gene result in heightened interferon signaling and impaired IL-17 immunity. While chronic mucocutaneous candidiasis (CMC) remains the hallmark feature, affected individuals often display a broader phenotype including viral infections, mycobacterial susceptibility, and autoimmune diseases. We describe a 4-year-old girl who initially presented with abdominal pain and was diagnosed with acute appendicitis. During surgery, marked mesenteric lymphadenopathy was discovered, and histopathology revealed acid-fast bacilli. Mycobacterium tuberculosis was confirmed by gastric fluid PCR, prompting initiation of anti-tuberculosis therapy. Her past medical history included hospitalization for herpes zoster and recurrent episodes of oral candidiasis during febrile illnesses. Immunologic evaluation showed normal immunoglobulin levels, vaccine responses, oxidative burst, and lymphocyte proliferation. However, low NK cells, reduced recent thymic emigrants, and decreased class-switched memory B cells were noted. Genetic testing revealed a previously unreported heterozygous STAT1 variant (p.Thr387Arg), classified as likely pathogenic according to ACMG criteria with a CADD score of 23.4. Parental genetic testing was negative, suggesting a de novo mutation. Although STAT1 phosphorylation could not be assessed, the proportion of IL-17–producing CD4⁺ T cells was markedly reduced, supporting impaired Th17 immunity. Based on clinical, immunologic, and genetic findings, a clinical and immunological phenotype consistent with STAT1 GOF was established. One year later, the patient developed arthritis and was diagnosed with systemic lupus erythematosus (SLE) based on autoantibody positivity and low complement levels. During follow-up, she also developed hemophagocytic lymphohistiocytosis (HLH), further reflecting severe immune dysregulation. Ruxolitinib was initiated as bridging therapy, resulting in partial clinical improvement, and hematopoietic stem cell transplantation (HSCT) was planned as definitive therapy. This report describes a novel STAT1 variant consistent with a gain-of-function phenotype associated with disseminated tuberculosis and early-onset SLE, expanding the clinical and molecular spectrum of this disorder. In children presenting with overlapping infectious and autoimmune features, underlying inborn errors of immunity should be considered. The online version contains supplementary material available at 10.1007/s10875-026-02040-y.
- 19 June 2026
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 46 (1)
Open AccessDisseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report
Gain-of-function (GOF) mutations in the STAT1 gene result in heightened interferon signaling and impaired IL-17 immunity. While chronic mucocutaneous candidiasis (CMC) remains the hallmark feature, affected individuals often display a broader phenotype including viral infections, mycobacterial susceptibility, and autoimmune diseases. We describe a 4-year-old girl who initially presented with abdominal pain and was diagnosed with acute appendicitis. During surgery, marked mesenteric lymphadenopathy was discovered, and histopathology revealed acid-fast bacilli. Mycobacterium tuberculosis was confirmed by gastric fluid PCR, prompting initiation of anti-tuberculosis therapy. Her past medical history included hospitalization for herpes zoster and recurrent episodes of oral candidiasis during febrile illnesses. Immunologic evaluation showed normal immunoglobulin levels, vaccine responses, oxidative burst, and lymphocyte proliferation. However, low NK cells, reduced recent thymic emigrants, and decreased class-switched memory B cells were noted. Genetic testing revealed a previously unreported heterozygous STAT1 variant (p.Thr387Arg), classified as likely pathogenic according to ACMG criteria with a CADD score of 23.4. Parental genetic testing was negative, suggesting a de novo mutation. Although STAT1 phosphorylation could not be assessed, the proportion of IL-17–producing CD4⁺ T cells was markedly reduced, supporting impaired Th17 immunity. Based on clinical, immunologic, and genetic findings, a clinical and immunological phenotype consistent with STAT1 GOF was established. One year later, the patient developed arthritis and was diagnosed with systemic lupus erythematosus (SLE) based on autoantibody positivity and low complement levels. During follow-up, she also developed hemophagocytic lymphohistiocytosis (HLH), further reflecting severe immune dysregulation. Ruxolitinib was initiated as bridging therapy, resulting in partial clinical improvement, and hematopoietic stem cell transplantation (HSCT) was planned as definitive therapy. This report describes a novel STAT1 variant consistent with a gain-of-function phenotype associated with disseminated tuberculosis and early-onset SLE, expanding the clinical and molecular spectrum of this disorder. In children presenting with overlapping infectious and autoimmune features, underlying inborn errors of immunity should be considered. The online version contains supplementary material available at 10.1007/s10875-026-02040-y.
- Open Access
- 13 June 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
- 13 June 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Open AccessBeyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
- 5 May 2026
- Published by SAGE Publications in Pediatric Allergy, Immunology, and Pulmonology
- Vol. 39 (1-2) , 44-47
From Idiopathic to Identifiable: Oral Mite Sensitization Revealed by Component-Resolved Diagnostics
Introduction:: Oral mite anaphylaxis (OMA) is an uncommon form of food-induced anaphylaxis caused by ingestion of foods contaminated with house dust mites. Exercise may act as a cofactor, sometimes mimicking food-dependent exercise-induced anaphylaxis (FDEIA). Case Presentation:: We describe a 14-year-old boy with atopic dermatitis, allergic rhinitis, and mild asthma who experienced three episodes of anaphylaxis. Each reaction occurred 30–60 min after eating wheat-based foods, followed by physical activities such as football or basketball. Symptoms started with urticaria and progressed to cough and abdominal pain. Notably, he tolerated the same foods in the absence of exercise. Skin prick testing and specific IgE showed strong sensitization to Dermatophagoides pteronyssinus and Dermatophagoides farinae , but not to wheat. Multiplex component testing confirmed broad mite sensitization. Evaluation for primary immunodeficiency was unremarkable. The patient was prescribed an epinephrine auto-injector, and asthma therapy was optimized with budesonide/formoterol. Over 6 months of follow-up, no further episodes occurred, asthma control improved (Asthma Control Test score 24–25), and rhinitis symptoms subsided with intranasal antihistamines. Discussion:: The clinical picture, together with negative wheat-specific IgE and strong mite sensitization, supported OMA rather than classical food allergy or FDEIA. Component-resolved diagnostics were especially helpful in confirming the diagnosis. Conclusion:: This case underlines the importance of considering OMA in children with exercise-related anaphylaxis after wheat-based meals, particularly in patients who may initially appear to have idiopathic anaphylaxis. Careful history, use of CRD, and close follow-up are essential. Education, asthma control, and preventive measures remain key to reducing recurrence risk.
- 5 May 2026
- Published by SAGE Publications in Pediatric Allergy, Immunology, and Pulmonology
- Vol. 39 (1-2) , 44-47
From Idiopathic to Identifiable: Oral Mite Sensitization Revealed by Component-Resolved Diagnostics
Introduction:: Oral mite anaphylaxis (OMA) is an uncommon form of food-induced anaphylaxis caused by ingestion of foods contaminated with house dust mites. Exercise may act as a cofactor, sometimes mimicking food-dependent exercise-induced anaphylaxis (FDEIA). Case Presentation:: We describe a 14-year-old boy with atopic dermatitis, allergic rhinitis, and mild asthma who experienced three episodes of anaphylaxis. Each reaction occurred 30–60 min after eating wheat-based foods, followed by physical activities such as football or basketball. Symptoms started with urticaria and progressed to cough and abdominal pain. Notably, he tolerated the same foods in the absence of exercise. Skin prick testing and specific IgE showed strong sensitization to Dermatophagoides pteronyssinus and Dermatophagoides farinae , but not to wheat. Multiplex component testing confirmed broad mite sensitization. Evaluation for primary immunodeficiency was unremarkable. The patient was prescribed an epinephrine auto-injector, and asthma therapy was optimized with budesonide/formoterol. Over 6 months of follow-up, no further episodes occurred, asthma control improved (Asthma Control Test score 24–25), and rhinitis symptoms subsided with intranasal antihistamines. Discussion:: The clinical picture, together with negative wheat-specific IgE and strong mite sensitization, supported OMA rather than classical food allergy or FDEIA. Component-resolved diagnostics were especially helpful in confirming the diagnosis. Conclusion:: This case underlines the importance of considering OMA in children with exercise-related anaphylaxis after wheat-based meals, particularly in patients who may initially appear to have idiopathic anaphylaxis. Careful history, use of CRD, and close follow-up are essential. Education, asthma control, and preventive measures remain key to reducing recurrence risk.
- 24 April 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 103 (4) , e70116
Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation
Recombination‐activating genes (RAG1 and RAG2) encode lymphoid‐specific proteins that are essential for V(D)J recombination during early T‐ and B‐lymphocyte development. Biallelic mutations in these genes result in a broad spectrum of primary immunodeficiency phenotypes, ranging from classical severe combined immunodeficiency (SCID) to combined immunodeficiency, immune dysregulation, autoimmunity, and inflammatory complications. The immunological phenotype varies widely, from T‐B‐NK+ severe combined immunodeficiency (SCID) to combined immunodeficiency (CID), or near‐normal T and B cell counts, and even antibody deficiencies despite preserved pathogen‐specific antibody responses. In this cohort, we aimed to characterize the clinical, immunological, and genetic features, as well as the disease course, of patients diagnosed with RAG1 and RAG2 deficiencies.
- 24 April 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 103 (4) , e70116
Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation
Recombination‐activating genes (RAG1 and RAG2) encode lymphoid‐specific proteins that are essential for V(D)J recombination during early T‐ and B‐lymphocyte development. Biallelic mutations in these genes result in a broad spectrum of primary immunodeficiency phenotypes, ranging from classical severe combined immunodeficiency (SCID) to combined immunodeficiency, immune dysregulation, autoimmunity, and inflammatory complications. The immunological phenotype varies widely, from T‐B‐NK+ severe combined immunodeficiency (SCID) to combined immunodeficiency (CID), or near‐normal T and B cell counts, and even antibody deficiencies despite preserved pathogen‐specific antibody responses. In this cohort, we aimed to characterize the clinical, immunological, and genetic features, as well as the disease course, of patients diagnosed with RAG1 and RAG2 deficiencies.
- 9 November 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (5) , e70063
Expansion of Myeloid‐Derived Suppressor Cells and Lymphocyte Apoptosis Beyond B‐Cell Deficiency in X‐Linked Agammaglobulinemia
X‐linked agammaglobulinemia (XLA) is caused by Bruton tyrosine kinase gene mutations, leading to B‐cell deficiency. This study aimed to investigate myeloid‐derived suppressor cells (MDSCs) frequency, lymphocyte apoptosis and clinical significance in patients with XLA. The study comprised 46 paediatric (mean age: 9.9 ± 4.8 years) and 21 adult patients (24.6 ± 5.9 years). Total MDSCs (HLA‐DR − CD33 + CD11b + ) were subdivided into CD15 + polymorphonuclear (PMN‐MDSCs) and CD14 + monocytic (M‐MDSCs) and analysed by flow cytometry. The paediatric XLA patients had increased M‐MDSCs and early apoptotic lymphocyte frequency compared to healthy subjects. The mean diagnostic delay was positively correlated with early apoptotic CD3 + and CD4 + T‐cells. Seventeen patients (14 adults and 3 children) had bronchiectasis. PMN‐MDSCs were higher in adult patients than in paediatric patients. Increased PMN‐MDSCs in adults with XLA suggest the presence of chronic inflammation in patients with bronchiectasis. The study findings broaden understanding of XLA's complex immunopathology and highlight the need for more comprehensive immune monitoring of these patients beyond antibody production.
- 9 November 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (5) , e70063
Expansion of Myeloid‐Derived Suppressor Cells and Lymphocyte Apoptosis Beyond B‐Cell Deficiency in X‐Linked Agammaglobulinemia
X‐linked agammaglobulinemia (XLA) is caused by Bruton tyrosine kinase gene mutations, leading to B‐cell deficiency. This study aimed to investigate myeloid‐derived suppressor cells (MDSCs) frequency, lymphocyte apoptosis and clinical significance in patients with XLA. The study comprised 46 paediatric (mean age: 9.9 ± 4.8 years) and 21 adult patients (24.6 ± 5.9 years). Total MDSCs (HLA‐DR − CD33 + CD11b + ) were subdivided into CD15 + polymorphonuclear (PMN‐MDSCs) and CD14 + monocytic (M‐MDSCs) and analysed by flow cytometry. The paediatric XLA patients had increased M‐MDSCs and early apoptotic lymphocyte frequency compared to healthy subjects. The mean diagnostic delay was positively correlated with early apoptotic CD3 + and CD4 + T‐cells. Seventeen patients (14 adults and 3 children) had bronchiectasis. PMN‐MDSCs were higher in adult patients than in paediatric patients. Increased PMN‐MDSCs in adults with XLA suggest the presence of chronic inflammation in patients with bronchiectasis. The study findings broaden understanding of XLA's complex immunopathology and highlight the need for more comprehensive immune monitoring of these patients beyond antibody production.
- 15 June 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (6) , e70031
Enhancing Primary Immunodeficiency Diagnosis: Findings From Targeted Genetic Testing in a Turkish Cohort
Primary immunodeficiency disorders (PIDDs) comprise a heterogeneous group of genetic conditions characterised by recurrent infections, immune dysregulation and increased susceptibility to malignancies. While clinical evaluation remains essential for diagnosis, genetic testing plays a pivotal role in confirming the diagnosis and guiding management. This cross‐sectional study evaluates the diagnostic yield and clinical utility of targeted gene panel testing in patients with a strong clinical suspicion of PIDDs, within the framework of the Jeffrey Modell Foundation's ‘Jeffrey's Insights’ programme. Between 2022 and 2024, 104 patients without a prior genetic diagnosis were evaluated at the Department of Paediatric Allergy and Clinical Immunology, Başakşehir Çam and Sakura City Hospital, Türkiye. In 72 of 104 patients, the identified variants were consistent with clinical phenotypes. Pathogenic or likely pathogenic variants were identified in 41.3% of patients, increasing to 57.7% when including variants of uncertain significance (VUS) with high CADD scores. Genetic findings prompted reclassification of International Union of Immunological Societies (IUIS) categories in 25% of cases. Autosomal recessive inheritance and parental consanguinity were notable, reflecting regional genetic patterns. Failure to thrive and low switched memory B cell percentages were significantly associated with confirmed genetic diagnoses, while food allergy, viral skin infections and eczema were more common in genetically undiagnosed patients. These findings support the clinical value of targeted gene panels as an effective, accessible and informative tool in the diagnosis and classification of PIDDs, enhancing precision in patient care and enabling tailored therapeutic strategies.
- 15 June 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (6) , e70031
Enhancing Primary Immunodeficiency Diagnosis: Findings From Targeted Genetic Testing in a Turkish Cohort
Primary immunodeficiency disorders (PIDDs) comprise a heterogeneous group of genetic conditions characterised by recurrent infections, immune dysregulation and increased susceptibility to malignancies. While clinical evaluation remains essential for diagnosis, genetic testing plays a pivotal role in confirming the diagnosis and guiding management. This cross‐sectional study evaluates the diagnostic yield and clinical utility of targeted gene panel testing in patients with a strong clinical suspicion of PIDDs, within the framework of the Jeffrey Modell Foundation's ‘Jeffrey's Insights’ programme. Between 2022 and 2024, 104 patients without a prior genetic diagnosis were evaluated at the Department of Paediatric Allergy and Clinical Immunology, Başakşehir Çam and Sakura City Hospital, Türkiye. In 72 of 104 patients, the identified variants were consistent with clinical phenotypes. Pathogenic or likely pathogenic variants were identified in 41.3% of patients, increasing to 57.7% when including variants of uncertain significance (VUS) with high CADD scores. Genetic findings prompted reclassification of International Union of Immunological Societies (IUIS) categories in 25% of cases. Autosomal recessive inheritance and parental consanguinity were notable, reflecting regional genetic patterns. Failure to thrive and low switched memory B cell percentages were significantly associated with confirmed genetic diagnoses, while food allergy, viral skin infections and eczema were more common in genetically undiagnosed patients. These findings support the clinical value of targeted gene panels as an effective, accessible and informative tool in the diagnosis and classification of PIDDs, enhancing precision in patient care and enabling tailored therapeutic strategies.
- Open Access
- 18 February 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (2) , e70003
Evaluation of T‐cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects
The group of patients with DNA‐repair‐defects increases susceptibility to infections due to impaired repertoire diversity. In this context, we aimed to investigate the TCRvβ‐repertoire by flow cytometric analysis and its correlation with clinical entities in a group of IEI patients with DNA repair defects. Peripheral lymphocyte subset and TCRvβ‐repertoire analyses were performed by flow cytometric analysis. The aim was to explore the changing TCR‐Vβ‐repertoire that can predict some clinical entities by investigating the repertoire using flow‐cytometric‐analysis‐based TCR‐Vβ and its interaction with clinical entities in a group of IEI patients with DNA repair defects. TCR‐repertoire of the patients with DNA‐repair‐defects and healthy controls was analysed with flow‐cytometer. The potential of flow‐cytometric analysis of the TCR repertoire as a practical and easily accessible clinical prediction method was investigated. Thirty‐nine‐IEI patients with DNA‐repair‐defects and 15 age‐matched healthy‐controls were included in this study. Peripheral lymphocyte subset and TCR‐Vβ repertoire analyses were performed by flow cytometry. Compared to the control group, 9 out of 24 clones (37.5%) exhibited a statistically significant reduction, while only 3 clones showed a statistically significant increase (p < 0.05). Preferential use of vβ‐genes was associated with some clinical entities. Lower TCR‐vβ‐9 and TCR‐vβ23, higher TCR‐vβ7.2 were found in the patients with pneumonia (n = 13) (p = 0.018, p = 0.044 p = 0.032). AT patients with pneumonia had lower TCR‐vβ‐9 clone than patients without pneumonia (p = 0.008). Skewed proliferation of most TCR‐vβ clones was seen DNA‐repair‐defects, especially AT. In addition, this study showed that preferential use of TCR‐vβ genes could be predictive for some clinical entities.
- 18 February 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (2) , e70003
Open AccessEvaluation of T‐cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects
The group of patients with DNA‐repair‐defects increases susceptibility to infections due to impaired repertoire diversity. In this context, we aimed to investigate the TCRvβ‐repertoire by flow cytometric analysis and its correlation with clinical entities in a group of IEI patients with DNA repair defects. Peripheral lymphocyte subset and TCRvβ‐repertoire analyses were performed by flow cytometric analysis. The aim was to explore the changing TCR‐Vβ‐repertoire that can predict some clinical entities by investigating the repertoire using flow‐cytometric‐analysis‐based TCR‐Vβ and its interaction with clinical entities in a group of IEI patients with DNA repair defects. TCR‐repertoire of the patients with DNA‐repair‐defects and healthy controls was analysed with flow‐cytometer. The potential of flow‐cytometric analysis of the TCR repertoire as a practical and easily accessible clinical prediction method was investigated. Thirty‐nine‐IEI patients with DNA‐repair‐defects and 15 age‐matched healthy‐controls were included in this study. Peripheral lymphocyte subset and TCR‐Vβ repertoire analyses were performed by flow cytometry. Compared to the control group, 9 out of 24 clones (37.5%) exhibited a statistically significant reduction, while only 3 clones showed a statistically significant increase (p < 0.05). Preferential use of vβ‐genes was associated with some clinical entities. Lower TCR‐vβ‐9 and TCR‐vβ23, higher TCR‐vβ7.2 were found in the patients with pneumonia (n = 13) (p = 0.018, p = 0.044 p = 0.032). AT patients with pneumonia had lower TCR‐vβ‐9 clone than patients without pneumonia (p = 0.008). Skewed proliferation of most TCR‐vβ clones was seen DNA‐repair‐defects, especially AT. In addition, this study showed that preferential use of TCR‐vβ genes could be predictive for some clinical entities.